In a study of experimental autoimmune myocarditis induced by cardiac troponin-I immunization (CTPN: SMD: 37.93, 95% CI 4.28, 71.58, p = 0.03), both the biomolecules, HMGB1 and RAGE (not computed) were considered as potential therapeutic targets in heart failure treatment, given the ability of HMGB1 to stimulate immunity and their ability to interact with each other, RAGE being its principal binding partner in both preclinical and clinical studies
Understanding their relationship helps clarify dosing comparisons
Related Topics Peptide Calculator General-purpose reconstitution and dosing calculator Peptide Reconstitution Guide General bacteriostatic water and syringe handling Where to Inject KLOW Peptide Standard subcutaneous sites and rotation BPC-157 Guide Standalone dosing, pharmacokinetics, oral vs injectable TB-500 / TB-4 Guide Fragment vs full-length, CoA verification, threshold-saturation mechanism GHK-Cu Guide Copper peptide mechanism for skin and matrix quality KPV Guide Anti-inflammatory mechanism, gut and skin applications NAD+ Deep Dive Cellular energy support for intensive repair cycles References GHK-Cu tissue-organization signaling and copper-peptide complex TGF-/Smad matrix organization, lysyl oxidase cross-linking, SOD/catalase antioxidant expression, copper coordination chemistry, 4,000+ gene modulation: PubMed 29986520
AACR Abstract 2019